Milestone Pharmaceuticals Inc (MIST) — Financial Flexibility Index
Milestone Pharmaceuticals Inc (MIST) has a Financial Flexibility Index of -0.15x as of September 2025. Free cash flow of $-9.81 Million (operating CF $-9.82 Million minus capex $1.98K) represents 0% of total liabilities ($67.25 Million). Check cash flow reinvestment rate of Milestone Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Milestone Pharmaceuticals Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Milestone Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see Milestone Pharmaceuticals Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Milestone Pharmaceuticals Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Milestone Pharmaceuticals Inc. Explore MIST debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.46x | $-28.82 Million | $-28.85 Million | $62.35 Million | ▲ +41.7% |
| 2023 | -0.79x | $-46.31 Million | $-46.42 Million | $58.45 Million | ▲ +87.7% |
| 2022 | -6.42x | $-52.20 Million | $-52.47 Million | $8.13 Million | ▼ -40.0% |
| 2021 | -4.58x | $-33.22 Million | $-33.22 Million | $7.25 Million | ▲ +38.0% |
| 2020 | -7.39x | $-50.63 Million | $-50.73 Million | $6.86 Million | ▼ -23.9% |
| 2019 | -5.96x | $-50.74 Million | $-51.15 Million | $8.51 Million | ▼ -3959.9% |
| 2018 | -0.15x | $-21.04 Million | $-21.05 Million | $143.29 Million | ▼ -11.2% |
| 2017 | -0.13x | $-8.02 Million | $-8.05 Million | $60.71 Million | — |